Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rory Collins

Showing results (1-10 of 267) with videos related to

Pageof 27
Sort By:
European Journal of Preventive Cardiology|June 25, 2014
Lack of adverse effect of statin therapy on common muscle-related adverse eventsRory Collins
Lancet (London, England)|April 3, 2012
What makes UK Biobank special?Rory Collins
The American Journal of Managed Care|February 9, 2002
Heart protection study finds simvastatin reduces vascular risk in a wide range of high-risk patientsRory Collins
European Heart Journal|June 25, 2013
Sensible guidelines for clinical trials: are current European regulations 'a gift to America'? Interview by Barry ShurlockRory Collins
Lancet (London, England)|November 30, 2002
High-risk elderly patients PROSPER from cholesterol-lowering therapyRory Collins, Jane Armitage
Circulation|October 26, 2018
Trust the Blinded Randomized Evidence That Statin Therapy Rarely Causes Symptomatic Side EffectsRichard Peto, Rory Collins
BMJ (Clinical Research Ed.)|August 12, 2006
Balancing potential risks and benefits of using confidential dataChristina Davies, Rory Collins
JAMA|November 25, 2010
Enhancing the feasibility of large cohort studiesTeri A Manolio, Rory Collins
American Journal of Epidemiology|January 9, 2013
Counterpoint: "streamlined" does not mean simpleTeri A Manolio, Rory Collins,
American Journal of Epidemiology|January 9, 2013
Vehement agreement on new models?Teri A Manolio, Rory Collins,
Pageof 27

Showing results (1-10 of 267) with videos related to

Sort By:
Pageof 27
European Journal of Preventive Cardiology|June 25, 2014
Lack of adverse effect of statin therapy on common muscle-related adverse eventsRory Collins
Lancet (London, England)|April 3, 2012
What makes UK Biobank special?Rory Collins
The American Journal of Managed Care|February 9, 2002
Heart protection study finds simvastatin reduces vascular risk in a wide range of high-risk patientsRory Collins
European Heart Journal|June 25, 2013
Sensible guidelines for clinical trials: are current European regulations 'a gift to America'? Interview by Barry ShurlockRory Collins
Lancet (London, England)|November 30, 2002
High-risk elderly patients PROSPER from cholesterol-lowering therapyRory Collins, Jane Armitage
Circulation|October 26, 2018
Trust the Blinded Randomized Evidence That Statin Therapy Rarely Causes Symptomatic Side EffectsRichard Peto, Rory Collins
BMJ (Clinical Research Ed.)|August 12, 2006
Balancing potential risks and benefits of using confidential dataChristina Davies, Rory Collins
JAMA|November 25, 2010
Enhancing the feasibility of large cohort studiesTeri A Manolio, Rory Collins
American Journal of Epidemiology|January 9, 2013
Counterpoint: "streamlined" does not mean simpleTeri A Manolio, Rory Collins,
American Journal of Epidemiology|January 9, 2013
Vehement agreement on new models?Teri A Manolio, Rory Collins,
Pageof 27